Stay updated with breaking news from Nasdaq Abcl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) traded down 3.7% on Tuesday . The stock traded as low as $4.40 and last traded at $4.41. 577,359 shares changed hands during trading, a decline of 60% from the average session volume of 1,439,832 shares. The stock had previously closed at $4.58. Analyst Ratings Changes A […]
AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) has earned a consensus rating of “Buy” from the nine brokerages that are covering the firm, Marketbeat.com reports. Nine research analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokers that have covered the stock in the last year is $15.86. […]
AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) has been assigned a consensus rating of “Buy” from the nine analysts that are covering the stock, MarketBeat reports. Nine research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have updated their coverage on the stock in the […]
Skandinaviska Enskilda Banken AB publ raised its holdings in AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) by 3.7% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 83,867 shares of the company’s stock after acquiring an additional 3,000 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in AbCellera Biologics were worth $386,000 at […]
Shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the ten analysts that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1-year price […]